Rose McGowan

home / authors / rose-mcgowan

Articles

Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Study lungs ©pascalkphoto/stock.adobe.com

Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Trial

Findings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.

Latest Updated Articles

Hard Purple Nodules: Your Dx?

Published: September 12th 2014 | Updated: February 6th 2025

Hard Purple Nodules: Your Dx?

3-Year-Old Boy With Unilateral Facial Swelling

Published: July 2nd 2015 | Updated: February 6th 2025

3-Year-Old Boy With Unilateral Facial Swelling

What's This "Red Spot"?

Published: January 29th 2014 | Updated: February 6th 2025

What's This "Red Spot"?

Rash Around the Mouth of a 5-year-old Child

Published: May 10th 2016 | Updated: February 6th 2025

Rash Around the Mouth of a 5-year-old Child

Scaly Plaque on the Nose

Published: June 15th 2013 | Updated: February 6th 2025

Scaly Plaque on the Nose

Elbow Erosions

Published: November 27th 2015 | Updated: February 6th 2025

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.